We’ve recently updated our valuation analysis.

ADC Therapeutics Valuation

Is ADCT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ADCT?

Other financial metrics that can be useful for relative valuation.

ADCT key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue3.5x
Enterprise Value/EBITDA-1.5x
PEG Ration/a

Price to Sales Ratio vs Peers

How does ADCT's PS Ratio compare to its peers?

ADCT PS Ratio vs Peers
The above table shows the PS ratio for ADCT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average13.9x
ATRA Atara Biotherapeutics
4.3x51.8%US$312.3m
EIGR Eiger BioPharmaceuticals
24.2x62.4%US$318.8m
OYST Oyster Point Pharma
5.6x51.2%US$178.7m
MIRM Mirum Pharmaceuticals
21.4x49.1%US$823.1m
ADCT ADC Therapeutics
4.2x30.0%US$390.9m

Price-To-Sales vs Peers: ADCT is good value based on its Price-To-Sales Ratio (4.2x) compared to the peer average (13.9x).


Price to Earnings Ratio vs Industry

How does ADCT's PE Ratio compare vs other companies in the US Biotechs Industry?

Price-To-Sales vs Industry: ADCT is good value based on its Price-To-Sales Ratio (4.2x) compared to the US Biotechs industry average (12.5x)


Price to Sales Ratio vs Fair Ratio

What is ADCT's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ADCT PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio4.2x
Fair PS Ratio1.9x

Price-To-Sales vs Fair Ratio: ADCT is expensive based on its Price-To-Sales Ratio (4.2x) compared to the estimated Fair Price-To-Sales Ratio (1.9x).


Share Price vs Fair Value

What is the Fair Price of ADCT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate ADCT's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate ADCT's fair value for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies